NCT02307071

Occipital Transcutaneous Stimulation in Chronic Migraine

Transcutaneous Suboccipital Neurostimulation for the Treatment of Chronic Migraine

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: University of Liege · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates the effect in chronic migraine patients of daily 20 minute-transcutaneous sub occipital neurostimulation using the occipital Cefaly° device.

Detailed description

Chronic migraine is a disabling neurological condition affecting 0.5-2% of the population. CM is difficult to treat and preventive treatment options are limited. Due to the inefficiency of available and the lack of new preventive anti-migraine drug, neurostimulation methods have raised great interest in recent years. The ONSTIM study showed a reduction in headache frequency in 39% of patients treated with active ONS during 12 weeks, compared to no improvement in the "non-effectively" stimulated or medically treated groups.

Conditions

• Chronic Migraine

Interventions

Type	Name	Description
DEVICE	Cefaly Kit Arnold	Occipital neurostimulation can have a therapeutic effect in chronic migraine treatment, thus representing a possible therapeutic option in patients that do not respond to any medication.

Timeline

• Start date: 2014-11-01
• Primary completion: 2015-09-01
• Completion: 2015-12-01
• First posted: 2014-12-03
• Last updated: 2015-05-28

Locations

1 site across 1 country: Belgium